Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

SRI-5

Known as: SRI 5 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Background and Aims SRI is a composite endpoint used in many SLE trials. The current investigation sought to identify those SRI… Expand
Is this relevant?
2016
2016
BAFF/BLyS, a pivotal cytokine in B-cell development, survival and proliferation,1 became a trusted target in systemic lupus… Expand
Is this relevant?
2016
2016
Introduction Les etudes controlees randomisees LUNAR et EXPLORER ayant etudie l’efficacite du rituximab dans le lupus… Expand
Is this relevant?
Highly Cited
2015
Highly Cited
2015
Objective To evaluate the efficacy and safety of subcutaneous blisibimod, an inhibitor of B cell activating factor, in patients… Expand
Is this relevant?
2015
2015
Background RNA gene expression profiling was performed on 1,760 SLE patients randomly selected from Illuminate Trials 1 & 2 which… Expand
Is this relevant?